Cheyne Capital Management (UK) LLP - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 165 filers reported holding NEKTAR THERAPEUTICS in Q4 2014. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cheyne Capital Management (UK) LLP ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2015$1,889,000
-56.0%
172,306
-49.9%
0.89%
-36.3%
Q2 2015$4,298,000
-33.7%
343,670
-41.7%
1.39%
-11.0%
Q1 2015$6,479,000
+19.9%
589,260
+69.1%
1.56%
+9.9%
Q4 2014$5,402,000
+94.9%
348,419
+51.8%
1.42%
+43.8%
Q3 2014$2,772,000229,5770.99%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2014
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 598,400$10,083,0003.98%
Opus Point Partners Management, LLC 348,583$5,874,0003.88%
Camber Capital Management LP 3,500,000$58,975,0003.81%
1492 Capital Management LLC 180,601$3,043,0002.21%
Virtus ETF Advisers LLC 38,260$645,0001.77%
Cormorant Asset Management, LP 765,156$12,893,0001.54%
Rhenman & Partners Asset Management AB 581,000$9,790,0001.48%
Granahan Investment Management 2,082,155$35,084,0001.21%
BRIDGER MANAGEMENT, LLC 1,563,862$26,351,0000.87%
RICE HALL JAMES & ASSOCIATES, LLC 899,531$15,157,0000.87%
View complete list of NEKTAR THERAPEUTICS shareholders